Publications by authors named "Ewa Puk"

Claim this Profile
A
Application of a novel PhysioCell apparatus for biopredictive dissolution tests of oral immediate release formulations - A case study workflow for in vitro-in vivo predictions.
Michał Romański, Marcela Staniszewska, Jadwiga Paszkowska, Justyna Dobosz, Svitlana Romanova, Ewa Puk

Int J Pharm· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically Based Dissolution Testing in a Drug Development Process-a Case Study of a Successful Application in a Bioequivalence Study of Trazodone ER Formulations Under Fed Conditions.
Dorota Danielak, Bartłomiej Milanowski, Krzysztof Wentowski, Maria Nogowska, Michał Kątny, Ewa Puk

AAPS PharmSciTech· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients.
Ewa Piotrowska, Joanna Jakobkiewicz-Banecka, Agnieszka Maryniak, Anna Tylki-Szymanska, Ewa Puk

Med Sci Monit· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients.
Ewa Piotrowska, Joanna Jakóbkiewicz-Banecka, Anna Tylki-Szymanska, Anna Liberek, Agnieszka Maryniak, Ewa Puk

Curr Ther Res Clin Exp· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The safety and tolerance of isoflavones (Soyfem) administration in postmenopausal women].
Krzysztof Drews, Agnieszka Seremak-Mrozikiewicz, Ewa Puk, Agnieszka Kaluba-Skotarczak, Magdalena Malec

Ginekol Pol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Efficacy of standardized isoflavones extract (Soyfem) (52-104 mg/24h) in moderate and medium-severe climacteric syndrome].
Krzysztof Drews, Agnieszka Seremak-Mrozikiewicz, Ewa Puk, Agnieszka Kaluba-Skotarczak, Magdalena Malec

Ginekol Pol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal fluid cytokines and sICAM-1 in minimal endometriosis: search for discriminating factors between infertility and/or endometriosis.
Jana Skrzypczak, Małgorzata Szczepańska, Ewa Puk, Marzena Kamieniczna, Maciej Kurpisz

Eur J Obstet Gynecol Reprod Biol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis